<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02927405</url>
  </required_header>
  <id_info>
    <org_study_id>926072</org_study_id>
    <nct_id>NCT02927405</nct_id>
  </id_info>
  <brief_title>Combination of Preoperative Gabapentin and TAP Blocks in Decreasing Postoperative Pain</brief_title>
  <official_title>Combination of Preoperative Gabapentin and TAP Blocks in Decreasing Postoperative Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>State University of New York - Downstate Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>State University of New York - Downstate Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is an increasing trend on decreasing narcotic use and maximizing efficiency in the&#xD;
      perioperative care. There are no studies that have compared a TAP block versus a TAP block&#xD;
      plus gabapentin for laparoscopic procures.This study will investigate if taking gabapentin&#xD;
      and receiving a TAP block decrease post-operative morphine consumption. It will be a&#xD;
      randomized controlled, double blind study, with 130 patients between 18-60 years; that will&#xD;
      undergo laparoscopic GYN procedures. Secondary outcomes will look at the incidence of nausea,&#xD;
      vomiting, and VAS (verbal analog scale) scores. This combination may be helpful because&#xD;
      gabapentin will be used to decrease visceral and central pain, and TAP block will decrease&#xD;
      somatic pain. Performing a multimodal approach may decrease narcotic consumption, adverse&#xD;
      effects and improve pain management.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Did not get the study to take off, did not recruit any subjects, and then closed the study.&#xD;
  </why_stopped>
  <start_date type="Anticipated">March 4, 2020</start_date>
  <completion_date type="Anticipated">March 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative morphine consumption</measure>
    <time_frame>24 hours after surgery.</time_frame>
    <description>Total amount of morphine the patient need to control post-operative pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>VAS Scores</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>Visual analog scale that rates a patient's pain</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Incidence of nausea and vomiting</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>How many times the patient reported nausea, and how many times they vomitted.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>TAP Block plus placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will only receive a TAP block procedure and then morphine consumption will be recorded.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TAP Block plus gabapentin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive a TAP block procedure and take pre-operative oral Gabapentin and morphine consumption will me recorded after surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gabapentin</intervention_name>
    <description>anticonvulsant drug that is used for neuropathic pain.</description>
    <arm_group_label>TAP Block plus gabapentin</arm_group_label>
    <other_name>Neurontin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TAP Block</intervention_name>
    <description>a procedure done anesthetize the anterior abdominal wall</description>
    <arm_group_label>TAP Block plus gabapentin</arm_group_label>
    <arm_group_label>TAP Block plus placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  female&#xD;
&#xD;
          -  receiving laparoscopic GYN procedure&#xD;
&#xD;
          -  between 18-60&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  are already taking gabapentin&#xD;
&#xD;
          -  have diabetic neuropathy&#xD;
&#xD;
          -  have a chronic pain syndrome&#xD;
&#xD;
          -  take opioids at home&#xD;
&#xD;
          -  are pregnant&#xD;
&#xD;
          -  have kidney disease&#xD;
&#xD;
          -  have an allergy to morphine&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>SUNY Downstate Medical Center</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>October 5, 2016</study_first_submitted>
  <study_first_submitted_qc>October 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2016</study_first_posted>
  <last_update_submitted>May 20, 2021</last_update_submitted>
  <last_update_submitted_qc>May 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>State University of New York - Downstate Medical Center</investigator_affiliation>
    <investigator_full_name>Shantha Ganesan</investigator_full_name>
    <investigator_title>Director, Pain Medicine</investigator_title>
  </responsible_party>
  <keyword>gabapentin</keyword>
  <keyword>TAP block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gabapentin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

